Review Article
Primary Hyperparathyroidism in Patients with Multiple Endocrine Neoplasia Type 1
Table 1
Tumours associated with MEN-1 and their penetrance.
| Localization | Clinical manifestation | Penetrance |
| Endocrine | | | Parathyroid | Primary hyperparathyroidism (bone demineralisation, kidney stones) | 90% | Enteropancreatic | | | Gastrinoma | Zollinger-Ellison syndrome (severe peptic ulceration) | 40% | Insulinoma | Recurrent neuroglycopenia | 10% | Nonfunctioning | Late diagnosis (symptoms related to tumor mass) | 20% | Other | WDHA syndrome, diabetes mellitus | 2% | Pituitary gland | | | Prolactinoma | Galactorrhea, menstrual period anomalies, reduced libido, erectile dysfunction, infertility | 20% | Other | Cushing syndrome, pituitary gland insufficiency | 17% | Adrenal | | | Nonfunctioning cortex | “Incidentaloma” | 20% | Pheochromocytoma | Paroxysmal or permanent arterial hypertension, paroxysmal tachyarrhythmia, diabetes mellitus | <1% | Foregut neuroendocrine tumours | | | Gastric | Carcinoid syndrome | 10% | Thymic | Carcinoid syndrome | 2% | Bronchial | Carcinoid syndrome, chronic cough | 2% |
| Nonendocrine | | | Facial angiofibromas | Local symptoms related to tumor mass | 85% | Collagenomas | Local symptoms related to tumor mass | 70% | Lipomas | Local symptoms related to tumor mass | 30% | Leiomyomas | Local symptoms related to tumor mass | 10% | Meningiomas | Intracranial pressure related symptoms | 5% | Ependymomas | Local symptoms related to tumor mass | 1% |
|
|